A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-tumor activity
Home ยป
Pembrolizumab Promising for Metastatic Head, Neck SCC
THURSDAY, Dec. 20, 2018 — For patients with recurrent or metastatic head and neck squamous cell carcinoma, pembrolizumab has a